期刊文献+

防止耐药菌的院内爆发 被引量:4

Preventing Hospital Outbreaks of Antibiotic-resistant Bacteria
下载PDF
导出
摘要 临床上多重耐药菌感染的现象正在日渐严重,从而引发了越来越严重的耐药菌院内感染现象。从医务工作者角度来控制这一现象的有效措施包括:规范医护人员的手卫生,控制侵入性操作引起的感染,合理使用抗生素,有效筛查和隔离疑似感染患者等。 The threat of infections due to multidrug-resistant organisms (MDROs) in clinical is increasing, and is causing serious hospital infections of drug-resistant bacteria. From the perspective of medical workers, effective measures to con- trol this phenomenon include: regulating the medical staff hand hygiene, controlling infections caused by invasive treat- ment, using rationally antibiotics, screening and isolating patients with suspected infection.
作者 刘利丹
机构地区 大连医科大学
出处 《医学与哲学(B)》 2013年第1期48-49,共2页 Medicine & Philosophy(B)
关键词 耐药菌 院内感染 手卫生 抗生素治疗 侵入性操作 antibiotic--resistant bacteria, hospital infections, hand hygiene, antibiotic therapy, invasive treatment
  • 相关文献

参考文献12

二级参考文献18

共引文献810

同被引文献44

  • 1熊薇.我国医院感染监控的当务之急[J].医学与哲学,2005,26(10X):48-50. 被引量:1
  • 2张峰铭,米军丽,吕志斌,刘云洁,李雁红,郭新梅,王远堂,耿堂忠.重症中暑11例治疗分析[J].临床军医杂志,2006,34(5):580-581. 被引量:18
  • 3机械通气临床应用指南(2006)[J].中国危重病急救医学,2007,19(2):65-72. 被引量:822
  • 4Yusuf E, Spapen H, Pierard D. Prolonged vs intermittent infusion of piperacillin/tazobactam in critically ill patients:A narrative and sys- tematic review[J]. J Crit Care,2014,29(6) :1089-1095.
  • 5Lodise T P, Lomaestro B M, Drusano G L. Application of antimicro bial pharmacodynamic concepts into clinical practice:Focus on ~-lac- tam antibiotics[J]. Pharmacotherapy,2006,26(9) :1320-1332.
  • 6De Wade J, Carlier M, Hoste E, et al. Extended versus bolus infu- sion of meropenem and piperacillin: a pharmacokinetic analysis[J]. Minerva Anestesiol,2014,80(12) : 1302-1309.
  • 7Carlier M,Carrette S,Roberts J A,et al. Meropenem and piperacil lin/tazobactam prescribing in critically ill patients: does augmented renal clearance affect pharmacokinetic/pharmacodynamic target at- tainment when extended infusions are used?FJ~. Crit Care, g013,17 (3) :R84.
  • 8Kim A,Sutherland C A,Kuti J L,et al. Optimal Dosing of Piperacil lin-Tazobactam for the Treatment of Pseudomonas aeruginosa In- fections:Prolonged or Continuous Infusion[J]. Pharmacotherapy, 2007,27(11) : 1490- 1497.
  • 9Langan K M,Jaeob J, Li J, et al. Pharmacokinetics of short versus extended infusion meropenem dosing in critically ill patients:a pilot study[J]. Crit Care Resusc,2014,16(3):190-196.
  • 10Felton T W, Hope W W, Lomaestro B M, et al. Population pharma cokinetics of extended-infusion piperacillin-tazobactam in hospital- ized patients with nosocomial infections[J]. Antimicrob Agents Chemother,2012,56(8) :4087-4094.

引证文献4

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部